NATCO Pharma Limited (BSE: 524816 | NSE: NATCOPHARM) has received approval from the Central Drugs Standard Control Organization (CDSCO) to manufacture and market generic Semaglutide Injection in India ...
The latest episode of Splitsvilla 16 delivered an intense moment when tensions flared between Preet and Keona during a discussion about Ayush’s exit. The disagreement began when it was pointed out by ...
Lionel Messi’s fitness has once again become a major talking point ahead of the 2026 FIFA World Cup after Inter Miami confirmed that the Argentine superstar has suffered a muscle strain in his left ...
Jefferies has upgraded Bharat Forge to Buy and raised its target price to ₹2,150, citing improving operational visibility. The brokerage noted that Q3 EBITDA grew 18% year-on-year, coming in 4% above ...
The Secret of Skinwalker Ranch is one of the most anticipated new reality shows on TV, known for its compelling scientific approach to unsolved paranormal cases, UFO sightings, and other unexplained ...
Shriram Finance on February 13 informed exchanges that the Reserve Bank of India (RBI) has confirmed that MUFG Bank Ltd is not required to obtain prior approval from the central bank for the proposed ...
Silver prices surged nearly 5% on Friday, with CFDs on silver climbing to $78.737 per ounce, up 4.67%, as investors positioned ahead of key U.S. inflation data that could influence the Federal Reserve ...
Gold prices recovered on Friday after sliding to a near one-week low in the previous session, as investors awaited key U.S. inflation data for clarity on the Federal Reserve’s interest rate path. Spot ...
Indian equity benchmarks traded sharply lower in midday deals on February 13 (IST), with the Nifty 50 slipping 0.95% to 25,563.20 and the Sensex declining 0.93% to 82,897.42. Broad-based selling was ...
The latest preview of Splitsvilla X6 has left viewers with intense curiosity after showing Kaira sitting in the power chair alongside Yogesh and breaking down emotionally. In the clip from the ...
Ipca Laboratories reported a steady performance for the quarter ended December 31, 2025, with profit growth outpacing revenue expansion on a year-on-year (YoY) basis. The pharmaceutical major ...
Jefferies has maintained its Buy rating on Mahindra & Mahindra with a target price of ₹4,500, citing consistent earnings delivery and demand-driven growth. Jefferies noted that the December quarter ...